Literature DB >> 15308720

Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly.

Kevin C Klein1, Stephen J Polyak, Jaisri R Lingappa.   

Abstract

The assembly of hepatitis C virus (HCV) is poorly understood, largely due to the lack of mammalian cell culture systems that are easily manipulated and produce high titers of virus. This problem is highlighted by the inability of the recently established HCV replicon systems to support HCV capsid assembly despite high levels of structural protein synthesis. Here we demonstrate that up to 80% of HCV core protein synthesized de novo in cell-free systems containing rabbit reticulocyte lysate or wheat germ extracts assembles into HCV capsids. This contrasts with standard primate cell culture systems, in which almost no core assembles into capsids. Cell-free HCV capsids, which have a sedimentation value of approximately 100S, have a buoyant density (1.28 g/ml) on cesium chloride similar to that of HCV capsids from other systems. Capsids produced in cell-free systems are also indistinguishable from capsids isolated from HCV-infected patient serum when analyzed by transmission electron microscopy. Using these cell-free systems, we show that HCV capsid assembly is independent of signal sequence cleavage, is dependent on the N terminus but not the C terminus of HCV core, proceeds at very low nascent chain concentrations, is independent of intact membrane surfaces, and is partially inhibited by cultured liver cell lysates. By allowing reproducible and quantitative assessment of viral and cellular requirements for capsid formation, these cell-free systems make a mechanistic dissection of HCV capsid assembly possible.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308720      PMCID: PMC506955          DOI: 10.1128/JVI.78.17.9257-9269.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector.

Authors:  Heather J Ezelle; Dubravka Markovic; Glen N Barber
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 2.  Introduction to therapy of hepatitis C.

Authors:  Karen L Lindsay
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

3.  Cell-free replication of the hepatitis C virus subgenomic replicon.

Authors:  Naushad Ali; Keith D Tardif; Aleem Siddiqui
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 4.  Molecular clones of hepatitis C virus: applications to animal models.

Authors:  M Gale ; M R Beard
Journal:  ILAR J       Date:  2001

5.  Separate assembly and transport domains within the Gag precursor of Mason-Pfizer monkey virus.

Authors:  M Sakalian; E Hunter
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

6.  In vitro RNA replication directed by replicase complexes isolated from the subgenomic replicon cells of hepatitis C virus.

Authors:  Vicky C H Lai; Shannon Dempsey; Johnson Y N Lau; Zhi Hong; Weidong Zhong
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

7.  Hepatitis C virus RNA synthesis in a cell-free system isolated from replicon-containing hepatoma cells.

Authors:  Richard W Hardy; Joseph Marcotrigiano; Keril J Blight; John E Majors; Charles M Rice
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  Processing of hepatitis C virus core protein is regulated by its C-terminal sequence.

Authors:  Takanobu Kato; Michiko Miyamoto; Akihiro Furusaka; Tomoko Date; Kotaro Yasui; Junko Kato; Shozo Matsushima; Tatsuji Komatsu; Takaji Wakita
Journal:  J Med Virol       Date:  2003-03       Impact factor: 2.327

9.  Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

Authors:  Keril J Blight; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

10.  Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture.

Authors:  Keril J Blight; Jane A McKeating; Joseph Marcotrigiano; Charles M Rice
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

View more
  28 in total

Review 1.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

2.  Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane.

Authors:  Christophe Hourioux; Malika Ait-Goughoulte; Romuald Patient; Delphine Fouquenet; Fabienne Arcanger-Doudet; Denys Brand; Annette Martin; Philippe Roingeard
Journal:  Cell Microbiol       Date:  2006-12-06       Impact factor: 3.715

3.  C-terminal domain of hepatitis C virus core protein is essential for secretion.

Authors:  Soo-Ho Choi; Kyu-Jin Park; So-Yeon Kim; Dong-Hwa Choi; Jung-Min Park; Soon-B Hwang
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

Review 4.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

5.  Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles.

Authors:  Pablo Gastaminza; Sharookh B Kapadia; Francis V Chisari
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

6.  Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features.

Authors:  Steeve Boulant; Christophe Vanbelle; Christine Ebel; François Penin; Jean-Pierre Lavergne
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Characterization of hepatitis C virus core protein multimerization and membrane envelopment: revelation of a cascade of core-membrane interactions.

Authors:  Li-Shuang Ai; Yu-Wen Lee; Steve S-L Chen
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

8.  Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding.

Authors:  Vineela Chukkapalli; Ian B Hogue; Vitaly Boyko; Wei-Shau Hu; Akira Ono
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

9.  Host-rabies virus protein-protein interactions as druggable antiviral targets.

Authors:  Usha F Lingappa; Xianfu Wu; Amanda Macieik; Shao Feng Yu; Andy Atuegbu; Michael Corpuz; Jean Francis; Christine Nichols; Alfredo Calayag; Hong Shi; James A Ellison; Emma K T Harrell; Vinod Asundi; Jaisri R Lingappa; M Dharma Prasad; W Ian Lipkin; Debendranath Dey; Clarence R Hurt; Vishwanath R Lingappa; William J Hansen; Charles E Rupprecht
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-12       Impact factor: 11.205

Review 10.  Hepatitis C virus proteins.

Authors:  Jean Dubuisson
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.